ROIV
Roivant Sciences Ltd.
October 21, 2026 · pre-market
- Rarity
- 2.27
- Peak move
- +10.24%
- Float cap
- $18.0B
Still running — rarity and peak move can only rise from here.
Roivant Sciences Ltd. is a biopharmaceutical company that develops and commercializes medicines for patients with unmet medical needs. It advances a pipeline of investigational therapies, including brepocitinib, IMVT-1402, and mosliciguat, through nimble subsidiaries called Vants. The company also incubates discovery-stage biopharmaceutical and health technology startups complementary to its core business.
Where do you see this going?
no votes yetVote to see the split.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNot searched yet.A blank here does not mean there was no cause.